Study of LAE102 with tirzepatide for weight loss in obesity
Part of Hormones & metabolism clinical trials.
This trial tests if adding LAE102 to tirzepatide (a weight loss drug) helps people with obesity lose more weight than tirzepatide alone. It is for adults who have tried diet and exercise but still struggle to lose weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- Your body mass index (BMI) is between 28 and 40 (a measure of weight relative to height)
- You have tried to lose weight with diet and exercise before, but it didn't work well
- Your weight has been stable (changed less than 5%) in the last 3 months without other treatments
- You do not have diabetes and your blood sugar levels are normal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if tirzepatide helps people with obesity lose weight, whether or not they have type 2 diabetes. It aims to see how safe and effective the drug is.
This trial is testing two drugs, NA-931 and tirzepatide, to see if they are safe and help adults who are overweight or obese lose weight. You may qualify if you have a high body mass index (BMI) and have tried to lose weight before without lasting success.
This trial tests an experimental drug called RN3161 to see if it helps with weight loss in people with overweight or obesity. It can be taken alone or with another weight-loss medication (tirzepatide).
This trial examines how well tirzepatide works for weight loss in people with obesity, and how it's actually used in daily life. It may be an option if you haven't tried other obesity treatments and don't have diabetes.
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
This trial tests if tirzepatide is more effective than standard obesity treatments for adults who have a BMI between 30 and 35 and one weight-related health condition, but do not have diabetes. The goal is to help you lose weight.
Hear when a new Obesity Adult Onset trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.